Co(x)Zn(1-x)Al(2)O(4) (x = 0.01-0.6) nanoparticles were synthesized by the citrate sol-gel method and were characterized by X-ray powder diffraction and transmission electron microscopy to identify the crystalline phase and determine the particle size. X-ray photoelectron spectroscopy and (27)Al solid-state NMR spectroscopy were used to study the distribution of the cations in the tetrahedral and octahedral sites in Co(x)Zn(1-x)Al(2)O(4) nanoparticles as a function of particle size and composition. The results show that all of the as-synthesized samples exhibit spinel-type single phase; the crystallite size of the samples is about 20-50 nm and increases with increasing annealing temperature and decreases with Co-enrichment. Zn(2+) ions are located in large proportions in the tetrahedral sites and in small proportions in the octahedral sites in Co(x)Zn(1-x)Al(2)O(4) nanoparticles. The fraction of octahedral Zn(2+) increases with increasing Co concentration and decreases with increasing particle size. Besides the tetrahedral and octahedral coordinations, the presence of the second octahedrally coordinated Al(3+) ions is observed in the nanoparticles. The change of the inversion parameter (2 times the fraction of Al(3+) ions in tetrahedral sites) with Co concentration and particle size is consistent with that of the Zn fraction in octahedral sites. Analysis of the absorption properties indicates that Co(2+) ions are located in the tetrahedral sites as well as in the octahedral sites in the nanoparticles. The inversion degree of Co(2+) decreases with increasing particle size.
X. (2013). Crystal growth, structure and thermal properties of noncentrosymmetric single crystals PrCa4O(BO3)3+. CrystEngComm, 15 (26), 5226-5231.Crystal growth, structure and thermal properties of noncentrosymmetric single crystals PrCa4O(BO3)3+
AbstractNoncentrosymmetric praseodymium calcium oxyborate single crystals, PrCa4O(BO3)3 (PrCOB), were grown by the Czochralski technique. The monoclinic unit cell parameters were found to be a = 8.177 Å, b = 16.157 Å, c = 3.629 Å and Z = 2 with space group Cm. Crystal density was measured using the Archimedes method, being on the order of 3.47 g cm-3. Thermal properties of PrCOB were investigated, where the specific heat was found to be 0.63 J g-1 °C-1 at room temperature, increasing to 0.85 J g-1°C-1 at 700°C. The thermal expansion coefficients were measured to be α11 = 7.99, α22 = 4.90 and α33 = 9.46 (10-6/°C), respectively. In addition, thermal diffusivity λ22 and thermal conductivity κ22 as a function of temperature were studied, where λ22 was observed to decrease from 0.89 to 0.58 mm2 s-1, while κ22 was found to maintain the same value, being ∼1.90 W m-1°C-1 over the temperature range of 20-700°C.
Piezoelectric ReCa4O(BO3)3 (ReCOB, Re: rare earth) crystals, including ErCOB, SmCOB, PrCOB and LaCOB, were successfully grown by the Czochralski (Cz) method. The dielectric constants were determined to be
,
and
for ErCOB,
,
and
for SmCOB,
,
and
for PrCOB,
,
and
for LaCOB, respectively. The electromechanical coupling factors k
26 and piezoelectric coefficients d
26 were found to be 18.5% (7.6 pC N−1), 27.0% (12.7 pC N−1), 31.5% (15.8 pC N−1) and 25.0% (11.8 pC N−1) for ErCOB, SmCOB, PrCOB and LaCOB crystals, respectively. The dielectric and piezoelectric properties as a function of Re3+ ion radius were studied, with maximum values being observed in the PrCOB crystals, due to the similar ion radius of Pr3+ and Ca2+. The relationship between the structure and dielectric/piezoelectric properties of ReCOB crystals was explored, to further optimize the dielectric and piezoelectric properties in ReCOB series crystals.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.